Qingson Tian

Title: The Innovations of Qingson Tian in Pharmaceutical Development

Introduction

Qingson Tian is a notable inventor based in Tianjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs for treating depression. His innovative work has led to the creation of a unique crystal form of Agomelatine, which is a key ingredient in his patented pharmaceutical compositions.

Latest Patents

Qingson Tian holds a patent for Agomelatine and pharmaceutical compositions thereof. This patent describes the Agomelatine crystal, which is specifically designed for treating depression. The patent details the X-ray powder diffraction spectra of the Agomelatine crystal, which exhibits characteristic diffraction peaks at 12.84, 13.84, 16.14, 18.56, 19.12, 20.86, 21.20, and 23.84 degrees. Additionally, the IR absorption pattern of the crystal shows significant absorption peaks at approximately 3234, 3060, 2940, 1638, 1511, 1436, 1249, 1215, 1184, 1032, 908, 828, 755, and 588 cm-1. The DSC endothermic transition temperature of the crystal is noted to be 97.6°C. This innovative formulation is aimed at enhancing the treatment options available for individuals suffering from depression.

Career Highlights

Qingson Tian is associated with Tianjin Taipu Pharmaceutical Science & Technology Development Co., Ltd. His work at this company has been pivotal in advancing pharmaceutical technologies and improving drug formulations. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Qingson Tian has collaborated with notable colleagues such as Jianqiang Zhu and Jian Zhao. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.

Conclusion

Qingson Tian's contributions to the field of pharmaceuticals, particularly through his patent on Agomelatine, highlight his role as an influential inventor. His work not only advances medical science but also provides new hope for those affected by depression.